Summary
Definição
História e exame físico
Principais fatores diagnósticos
- close contact with other infected individuals
- bright red macular erythema of the bilateral cheeks with sparing of the nasal ridge and perioral areas
- erythematous macules and papules evolving into lacy reticular erythema, most notable on the extremities
- immunodeficiency
Outros fatores diagnósticos
- arthralgia/arthritis
- prodrome (fever, headache, pharyngitis, coryza, abdominal pain)
- symptoms of anemia
Fatores de risco
- close contact with other infected individuals
- immunodeficiency
- age 6 to 10 years
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- clinical diagnosis
Investigações a serem consideradas
- CBC
- reticulocyte count
- serology
- DNA assays
Algoritmo de tratamento
fever
secondary arthritis
persistent (>3 weeks) parvovirus B19 infection
Colaboradores
Autores
Joseph M. Lam, MD
Clinical Associate Professor, Department of Pediatrics
Associate Member, Department of Dermatology and Skin Sciences
University of British Columbia, BC Children’s Hospital
Vancouver
BC
Canada
Divulgaciones
JML declares that he has no relevant competing interests.
Alexander K. C. Leung, MD
Department of Pediatrics
The University of Calgary, Alberta Children's Hospital
Calgary
Alberta
Canada
Divulgaciones
AKCL declares that he has no relevant competing interests.
Agradecimientos
Dr Joseph M. Lam and Dr Alexander Leung would like to gratefully acknowledge Dr Kari L. Martin, Dr Christine T. Lauren, Dr Jon Dyer, and Dr Jennifer Holman, the previous contributors to this topic. KLM has served as a board member for Women's Dermatologic Society and American Contact Dermatitis Society. CTL, JD, and JH declare that they have no competing interests.
Revisores por pares
Nevio Cimolai, MD
Professor
Department of Pathology and Laboratory Medicine
Children's and Women's Health Centre of British Columbia
Vancouver
Canada
Divulgaciones
NC declares that he has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350:586-597. Resumen
UK Health Security Agency. Parvovirus B19: guidance, data and analysis. Aug 2024 [internet publication].Texto completo
Cherry JD. Parvovirus infections in children and adults. Adv Pediatr. 1999;46:245-69. Resumen
Kimberlin DW, Banerjee R, Barnett ED, et al. Red book: 2024-2027 report of the Committee on Infectious Diseases. 33rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2024.
Centers for Disease Control and prevention. Parvovirus B19 and fifth disease. Nov 2019 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

Diferenciales
- Rubella
- Measles infection
- Roseola infantum
Más DiferencialesGuías de práctica clínica
- Parvovirus B19 and fifth disease
- Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy
Más Guías de práctica clínicaInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad